Lamotrigine (All indications)

Low Apgar score (< 7) (at 5 min)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S8961
R30349
Christensen (Lamotrigine) (Controls unexposed NOS) (Mixed indications), 2015 Low Apgar score (≤ 7) at 5 min during pregnancy (anytime or not specified) population based cohort propective unexposed (general population or NOS) excluded Adjustment: No 0.88 [0.47;1.62]
excluded (control group)
10/875   8,797/674,115 8,807 875
ref
S8962
R30350
Christensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Low Apgar score (≤ 7) at 5 min during pregnancy (anytime or not specified) population based cohort propective unexposed, sick Adjustment: No 0.90 [0.46;1.75] C 10/875   67/5,261 77 875
ref
S8902
R30058
Artama (Lamotrigine) (Controls unexposed, disease free), 2013 5-min Apgar <7 3rd trimester population based cohort retrospective unexposed, disease free excluded Adjustment: Yes 1.69 [0.53;5.36]
excluded (control group)
3/132   3,014/269,151 3,017 132
ref
S8903
R30070
Artama (Lamotrigine) (Controls unexposed, sick), 2013 5-min Apgar <7 3rd trimester population based cohort retrospective unexposed, sick Adjustment: Yes 1.89 [0.46;7.76] 3/132   3/652 6 132
ref
S8953
R30310
Veiby (Lamotrigine) (Controls unexposed, disease free) b, 2013 Low Apgar score (< 7 at 5 min) during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No 1.20 [0.30;4.80]
excluded (control group)
2/103   1,710/106,899 1,712 103
ref
S8954
R30324
Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Low Apgar score (< 7 at 5 min) during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No 0.83 [0.18;3.90] C 2/103   9/386 11 103
ref
S8957
R30338
Borthen (Lamotrigine) (Controls unexposed, disease free), 2010 Apgar < 7 after 5 minutes during pregnancy (anytime or not specified) population based cohort retrospective unexposed, disease free excluded Adjustment: Yes 1.90 [0.90;4.00]
excluded (control group)
7/233   6,022/362,302 6,029 233
ref
S8959
R30346
Borthen (Lamotrigine) (Controls unexposed, sick), 2010 Apgar < 7 after 5 minutes during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: No 1.89 [0.82;4.36] C 7/233   30/1,863 37 233
ref
Total 4 studies 1.22 [0.76;1.94] 131 1,343
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Christensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015Christensen, 2015 1 0.90[0.46; 1.75]7787549%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Artama (Lamotrigine) (Controls unexposed, sick), 2013Artama, 2013 2 1.89[0.46; 7.76]613211%ROB confusion: seriousROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013Veiby, 2013 3 0.83[0.18; 3.90]111039%ROB confusion: seriousROB selection: lowROB classification: lowROB missing: moderateROB mesure: moderateROB reporting: moderate Borthen (Lamotrigine) (Controls unexposed, sick), 2010Borthen, 2010 4 1.89[0.82; 4.36]3723331%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Total (4 studies) I2 = 0% 1.22[0.76; 1.94]1311,3430.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Lamotrigine) (Controls unexposed, sick) (Mixed indications; 2: Lamotrigine) (Controls unexposed, sick; 3: Lamotrigine) (Controls unexposed, sick) ; 4: Lamotrigine) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.22[0.76; 1.94]1311,3430%NAChristensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Artama (Lamotrigine) (Controls unexposed, sick), 2013 Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Borthen (Lamotrigine) (Controls unexposed, sick), 2010 4 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 1.22[0.76; 1.94]1311,3430%NAChristensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Artama (Lamotrigine) (Controls unexposed, sick), 2013 Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Borthen (Lamotrigine) (Controls unexposed, sick), 2010 4 Tags Adjustment   - No  - No 1.16[0.70; 1.93]1251,2114%NAChristensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Borthen (Lamotrigine) (Controls unexposed, sick), 2010 3   - Yes  - Yes 1.89[0.46; 7.76]6132 -NAArtama (Lamotrigine) (Controls unexposed, sick), 2013 1 All studiesAll studies 1.22[0.76; 1.94]1311,3430%NAChristensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Artama (Lamotrigine) (Controls unexposed, sick), 2013 Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Borthen (Lamotrigine) (Controls unexposed, sick), 2010 40.25.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-1.92.10.9480.000Christensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015Artama (Lamotrigine) (Controls unexposed, sick), 2013Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013Borthen (Lamotrigine) (Controls unexposed, sick), 2010

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 8957, 8902, 8953, 8961

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.26[0.83; 1.92]19,5651,3430%NAChristensen (Lamotrigine) (Controls unexposed NOS) (Mixed indications), 2015 Artama (Lamotrigine) (Controls unexposed, disease free), 2013 Veiby (Lamotrigine) (Controls unexposed, disease free) b, 2013 Borthen (Lamotrigine) (Controls unexposed, disease free), 2010 4 unexposed, sick controlsunexposed, sick controls 1.22[0.76; 1.94]1311,3430%NAChristensen (Lamotrigine) (Controls unexposed, sick) (Mixed indications), 2015 Artama (Lamotrigine) (Controls unexposed, sick), 2013 Veiby (Lamotrigine) (Controls unexposed, sick) b, 2013 Borthen (Lamotrigine) (Controls unexposed, sick), 2010 40.510.01.0